echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > President Song Ruilin meets with representatives of Japan Pharmaceutical Industry Association (JPMA)

    President Song Ruilin meets with representatives of Japan Pharmaceutical Industry Association (JPMA)

    • Last Update: 2014-09-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: China Association for the promotion of drugs September 12, 2014, song Ruilin, executive chairman of China Association for the promotion of drugs, met with Keisuke Watanabe, senior director of Takeda Pharmaceutical Co., Ltd., a visiting representative of Japan Pharmaceutical Industry Association (JPMA) in Beijing The two sides had in-depth and friendly exchanges on promoting cooperation between China and Japan and drug innovation in Asia President Song Ruilin first introduced the general situation of China Pharmaceutical Association President Song said that the Chinese government attaches great importance to drug innovation China's level in the field of new drug research and development is constantly improving, and the pharmaceutical market is huge Cooperation with developed countries, including Japan, is highly complementary China Council for the promotion of drugs is very pleased to establish close ties with Japan Pharmaceutical Industry Association and looks forward to multi-level and multi field cooperation in drug discovery and Policy Research on the basis of equality, mutual benefit and mutual respect Keisuke watanbe introduced JPMA and Asia partnership conference of pharmaceutical associations, APAC Conference) and warmly invite China Pharmaceutical Council to organize a delegation to attend APAC conference held in Japan in 2015, build an information sharing platform for the pharmaceutical industry in Asia, promote innovative drug research and development in Asia, propose solutions for the challenges faced by governments of all countries, and promote exchanges and cooperation between the pharmaceutical industry and academia in Asia The two sides agreed to actively explore cooperation opportunities in new drug research and development, information sharing in the pharmaceutical industry, and policy research, and constantly promote bilateral and Asia wide cooperation Hiroaki Yoshida, director of research and Development Department of JPMA, Kiyoshi Horie, head of international affairs of JPMA, and Chen Changxiong, Executive Deputy Secretary General of China Association for the promotion of drugs attended the meeting  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.